Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1997 Dec;167(6):433–435.

Long-term remission of HIV-associated thrombocytopenia parallels ongoing suppression of viral replication.

S C Zell 1, K Peterson 1
PMCID: PMC1304729  PMID: 9426488

Full text

PDF
433

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aster R. H. Thrombocytopenia in the HIV-infected patient. Hosp Pract (Off Ed) 1994 Aug 15;29(8):81–86. doi: 10.1080/21548331.1994.11443063. [DOI] [PubMed] [Google Scholar]
  2. Bettaieb A., Oksenhendler E., Duedari N., Bierling P. Cross-reactive antibodies between HIV-gp120 and platelet gpIIIa (CD61) in HIV-related immune thrombocytopenic purpura. Clin Exp Immunol. 1996 Jan;103(1):19–23. doi: 10.1046/j.1365-2249.1996.917606.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boyar A., Beall G. HIV-seropositive thrombocytopenia: the action of zidovudine. AIDS. 1991 Nov;5(11):1351–1356. [PubMed] [Google Scholar]
  4. Brogan K. L., Zell S. C. Hematologic toxicity of zidovudine in HIV-infected patients. Am Fam Physician. 1990 May;41(5):1521–1528. [PubMed] [Google Scholar]
  5. Carpenter C. C., Fischl M. A., Hammer S. M., Hirsch M. S., Jacobsen D. M., Katzenstein D. A., Montaner J. S., Richman D. D., Saag M. S., Schooley R. T. Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. JAMA. 1997 Jun 25;277(24):1962–1969. [PubMed] [Google Scholar]
  6. Carpenter C. C., Fischl M. A., Hammer S. M., Hirsch M. S., Jacobsen D. M., Katzenstein D. A., Montaner J. S., Richman D. D., Sáag M. S., Schooley R. T. Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA. JAMA. 1996 Jul 10;276(2):146–154. [PubMed] [Google Scholar]
  7. Cinque P., Landonio G., Lazzarin A., Nosari A. M., Ruggieri A., Coen M., Meraviglia P., Gringeri A., Gallo L., Quirino T. Long-term treatment with zidovudine in patients with human immunodeficiency virus (HIV)-associated thrombocytopenia: modes of response and correlation with markers of HIV replication. Eur J Haematol. 1993 Jan;50(1):17–21. doi: 10.1111/j.1600-0609.1993.tb00068.x. [DOI] [PubMed] [Google Scholar]
  8. Davis B. R., Zauli G. Effect of human immunodeficiency virus infection on haematopoiesis. Baillieres Clin Haematol. 1995 Mar;8(1):113–130. doi: 10.1016/s0950-3536(05)80234-3. [DOI] [PubMed] [Google Scholar]
  9. Glatt A. E., Anand A. Thrombocytopenia in patients infected with human immunodeficiency virus: treatment update. Clin Infect Dis. 1995 Aug;21(2):415–423. doi: 10.1093/clinids/21.2.415. [DOI] [PubMed] [Google Scholar]
  10. Goebel F. D. Combination therapy from a clinician's perspective. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10 (Suppl 1):S62–S68. [PubMed] [Google Scholar]
  11. Gonzalez-Conejero R., Rivera J., Rosillo M. C., Cano A., Rodriguez T., Vicente V. Association of autoantibodies against platelet glycoproteins Ib/IX and IIb/IIIa, and platelet-reactive anti-HIV antibodies in thrombocytopenic narcotic addicts. Br J Haematol. 1996 May;93(2):464–471. doi: 10.1046/j.1365-2141.1996.00502.x. [DOI] [PubMed] [Google Scholar]
  12. Harbol A. W., Liesveld J. L., Simpson-Haidaris P. J., Abboud C. N. Mechanisms of cytopenia in human immunodeficiency virus infection. Blood Rev. 1994 Dec;8(4):241–251. doi: 10.1016/0268-960x(94)90112-0. [DOI] [PubMed] [Google Scholar]
  13. Harrigan R. Measuring viral load in the clinical setting. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10 (Suppl 1):S34–S40. [PubMed] [Google Scholar]
  14. Jahnke L., Applebaum S., Sherman L. A., Greenberger P. A., Green D. An evaluation of intravenous immunoglobulin in the treatment of human immunodeficiency virus-associated thrombocytopenia. Transfusion. 1994 Sep;34(9):759–764. doi: 10.1046/j.1537-2995.1994.34994378275.x. [DOI] [PubMed] [Google Scholar]
  15. Landonio G., Cinque P., Nosari A., Gafa S., Rizzo F., Coen M., Tirelli U., Caggese L., di Luzio Paparatti U., Lazzarin A. Comparison of two dose regimens of zidovudine in an open, randomized, multicentre study for severe HIV-related thrombocytopenia. AIDS. 1993 Feb;7(2):209–212. doi: 10.1097/00002030-199302000-00008. [DOI] [PubMed] [Google Scholar]
  16. Landonio G., Cinque P., Nosari A., Gafa S., Rizzo F., Coen M., Tirelli U., Caggese L., di Luzio Paparatti U., Lazzarin A. Comparison of two dose regimens of zidovudine in an open, randomized, multicentre study for severe HIV-related thrombocytopenia. AIDS. 1993 Feb;7(2):209–212. doi: 10.1097/00002030-199302000-00008. [DOI] [PubMed] [Google Scholar]
  17. Landonio G., Nosari A., Spinelli F. HIV-related thrombocytopenia. N Engl J Med. 1993 Jun 17;328(24):1785–1786. [PubMed] [Google Scholar]
  18. Lange J. M. Triple combinations: present and future. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10 (Suppl 1):S77–S82. [PubMed] [Google Scholar]
  19. Luster M. I., Rosenthal G. J., Cao W., Thompson M. B., Munson A. E., Prejean J. D., Shopp G., Fuchs B. A., Germolec D. R., Tomaszewski J. E. Experimental studies of the hematologic and immune system toxicity of nucleoside derivatives used against HIV infection. Int J Immunopharmacol. 1991;13 (Suppl 1):99–107. doi: 10.1016/0192-0561(91)90131-p. [DOI] [PubMed] [Google Scholar]
  20. Merigan T. Individualization of therapy using viral markers. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10 (Suppl 1):S41–S46. [PubMed] [Google Scholar]
  21. Najean Y., Rain J. D. The mechanism of thrombocytopenia in patients with HIV infection. J Lab Clin Med. 1994 Mar;123(3):415–420. [PubMed] [Google Scholar]
  22. Northfelt D. W., Charlebois E. D., Mirda M. I., Child C., Kaplan L. D., Abrams D. I. Continuous low-dose interferon-alpha therapy for HIV-related immune thrombocytopenic purpura. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jan 1;8(1):45–50. [PubMed] [Google Scholar]
  23. Pottage J. C., Jr, Benson C. A., Spear J. B., Landay A. L., Kessler H. A. Treatment of human immunodeficiency virus-related thrombocytopenia with zidovudine. JAMA. 1988 Nov 25;260(20):3045–3048. doi: 10.1001/jama.260.20.3045. [DOI] [PubMed] [Google Scholar]
  24. Ramratnam B., Parameswaran J., Elliot B., Newstein M., Schiffman F. J., Rich J. D., Flanigan T. P. Short course dexamethasone for thrombocytopenia in AIDS. Am J Med. 1996 Jan;100(1):117–118. doi: 10.1016/s0002-9343(96)90020-0. [DOI] [PubMed] [Google Scholar]
  25. St Clair M., Pennington K. N., Rooney J., Barry D. W. Rapid screening of antiretroviral combinations. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10 (Suppl 1):S24–S27. [PubMed] [Google Scholar]
  26. Street A. M., Gibson J. Managing HIV. Part 5: Treating secondary outcomes. 5.12 HIV and haematological disease. Med J Aust. 1996 Apr 15;164(8):487–488. [PubMed] [Google Scholar]
  27. Zauli G., Catani L., Gibellini D., Re M. C., Vianelli N., Colangeli V., Celeghini C., Capitani S., La Placa M. Impaired survival of bone marrow GPIIb/IIa+ megakaryocytic cells as an additional pathogenetic mechanism of HIV-1-related thrombocytopenia. Br J Haematol. 1996 Mar;92(3):711–717. doi: 10.1046/j.1365-2141.1996.367904.x. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES